# Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer

> **NCT03301701** · NA · WITHDRAWN · sponsor: **Dr. Patrick Cheung**

## Conditions studied

- Hormone Sensitive Oligometastatic Prostate Cancer

## Interventions

- **PROCEDURE:** Radical prostatectomy
- **RADIATION:** HDR (19Gy) or SBRT (35-40Gy)

## Key facts

- **NCT ID:** NCT03301701
- **Lead sponsor:** Dr. Patrick Cheung
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09-22
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-05-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accruals
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03301701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03301701, "Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03301701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*